Cough drug safety checked in people with liver issues
Knowledge-focused
Completed
This early-stage study aimed to understand how a potential cough medicine, camlipixant, behaves in people with impaired liver function. It compared 32 adults with varying degrees of liver problems to healthy volunteers. The main goal was to see if the drug's processing and safety…
Phase: PHASE1 • Sponsor: Bellus Health Inc. - a GSK company • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC